Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools
<h4>Background</h4> The survival rate of head and neck squamous cell carcinoma (HNSCC) patients with secondary primary malignancy (SPM) showed no significant improvement for decades, however, the impact of advances in diagnostic tools is rarely mentioned. This study investigated the clin...
Main Authors: | Shih-Wei Wang, Leong-Perng Chan, Ling-Feng Wang, Che-Wei Wu, Sheng-Hsuan Lin, Tzu-Yen Huang, Ka-Wo Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846538/?tool=EBI |
Similar Items
-
Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma
by: Hui-Ching Wang, et al.
Published: (2019-10-01) -
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
by: Stefano Cavalieri, et al.
Published: (2021-12-01) -
Endoscopic Surveillance for Metachronous Esophageal Squamous Cell Neoplasms among Head and Neck Cancer Patients
by: Yi-Hsun Chen, et al.
Published: (2020-12-01) -
Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice
by: Hui-Ching Wang, et al.
Published: (2020-10-01) -
Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck.
by: Yu-Hsuan Hung, et al.
Published: (2018-01-01)